Additionally, GLP-1 activates related intracellular signaling pathways, promoting -cell regeneration, inhibiting -cell apoptosis, and improving -cell function, thereby lowering blood glucose levels, with its effects being glucose concentration-dependent (58, 59)
Khch ki tra hng tr khi thanh ton, giao nhanh ton qu
doi: 10.3390/foods14101749 75 PachalSKumarHJainRGoelBKesharwaniSKesharwaniSSet al
J Clin Endocrinol Metab 2008;93:68-75
Retatrutide is not currently FDA-approved for routine prescription use
For instance, in the DUAL VII study, 35% of those taking Xultophy achieved an A1C below 7% without hypoglycemia or weight gain, compared to only 5% of participants using basal-bolus insulin